| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_916075766043ce900399a4c2eee9f054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a26fbc85a633fe45a0f2618e337bb43 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1271 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-02 |
| filingDate |
1995-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8dfbbd5bbdcaf3145ffc698f3bbc721 |
| publicationDate |
1995-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9531183-A1 |
| titleOfInvention |
Cell membrane fusion composition and method |
| abstract |
A lipid vesicle composition for use in delivering a vesicle-encapsulated agent to a target cell is disclosed. The composition is formed of vesicle-forming lipids, including at least 10 mole percent plasmalogen phospholipid with a small-volume polar head group. The composition may also include a fusion protein for promoting fusion of the vesicles to the target cells. A novel fusion protein identified as an isoform of glyceraldehyde-3-phosphate dehydrogenase is also disclosed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6673364-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0164254-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11339209-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0164254-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004053118-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5885613-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6734171-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5820873-A |
| priorityDate |
1994-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |